The US Food and Drug Administration (FDA) today approved the drug edaravone (Radicava, Mitsubishi Tanabe Pharma America) to slow down functional decline in patients with amyotrophic lateral sclerosis (ALS).
US - RxList
Register to myHealthbox
get access to reserved documents
receive targeted news and alerts
bookmark your favourite products
save your latest searches.
Registration is free.
Are you from a Pharmaceutical or Healthcare Company?
myHealthbox can improve the online visibility of your products by as much as 20%.